StockNews.com Begins Coverage on Moleculin Biotech (NASDAQ:M

StockNews.com started coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Get Rating) in a report released on Monday. The brokerage issued a sell rating on the stock. MBRX has been the topic of a number of other research reports. Oppenheimer reaffirmed an outperform rating and set a $5.00 price objective on shares of Moleculin Biotech […]

Related Keywords

Houston , Texas , United States , Roth Mkm , Walterv Klemp , Moleculin Biotech Inc , Renaissance Technologies , Charles Schwab Investment Management Inc , Moleculin Biotech , Get Rating , Street Corp , Charles Schwab Investment Management , Waldemar Priebe , Moleculin Biotech Daily , Nasdaq Mbrx , Ambrx , Medical , Initiated Coverage , Stocknews Com ,